Replies to post #2098 on Moleculin Biotech Inc (MBRX)

[king oil]

That’s a good question. This company puts out loads of press releases about new potential benefits of the drug but almost no information regarding progress toward fda approvals. As the stock price is showing this strategy is beginning to fail.